Clinical Trials Browser

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms, Stomach Neoplasms

NCT07431281 2026-02-24

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Phase 3 Recruiting

2,130 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT03189719 2024-10-15

KEYNOTE-590

Phase 3 Completed

749 enrolled 40 charts 1 FDA

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms

NCT06501664 2024-07-15

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Phase 3 Not yet recruiting

360 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02509286 2024-05-08

ESOPEC

Phase 3 Active not recruiting

438 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT01726452 2022-09-30

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

Phase 3 Completed

377 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00002883 2021-02-23

Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus

Phase 3 Completed

250 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00052910 2020-05-07

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

Phase 3 Completed

546 enrolled 11 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00047112 2020-03-30

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

Phase 3 Completed

195 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03881111 2020-02-11

KEYNOTE-590

Phase 3 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT03366883 2018-01-09

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

Phase 3 Unknown

420 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00193882 2017-07-12

Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.

Phase 3 Completed

220 enrolled

Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms

NCT00190554 2016-09-22

A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

Phase 3 Terminated

330 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT00003118 2016-07-04

Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Phase 3 Completed

56 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01998347 2015-11-20

Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

Phase 3 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT00416858 2014-03-04

Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

Phase 3 Completed

40 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00002897 2013-09-20

Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus

Phase 3 Completed

240 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00002884 2013-08-07

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Phase 3 Unknown

326 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00559351 2007-11-16

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Phase 3 Terminated

84 enrolled

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Squamous Cell

Clinical Trials

HERIZON-GEA-01

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

KEYNOTE-590

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

ESOPEC

NEOadjuvant Trial in Adenocarcinoma of the oEsophagus and oesophagoGastric Junction International Study (Neo-AEGIS)

Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

KEYNOTE-590

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.

A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer

Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus